ClinConnect ClinConnect Logo
Search / Trial NCT06391294

Neuronal and Network Mechanisms of Electrocortical Stimulation

Launched by NORTHWESTERN UNIVERSITY · Apr 25, 2024

Trial Information

Current as of August 19, 2025

Enrolling by invitation

Keywords

Electrocortical Stimulation Electrocorticography

ClinConnect Summary

Electrocortical stimulation (ECS) mapping has been used routinely for many decades to inform surgeons on brain areas to avoid when planning surgical resections for tumors or epilepsy. In particular, those areas that are "critical" for speech and language are important to identify. Yet, despite its long history of clinical use, the precise mechanisms of ECS are poorly understood. For example, it is not known how different cortical layers and cell types respond to ECS. Moreover, it is not even clear whether ECS' behavioral effects are due to affecting the underlying cortex alone, causing tran...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Requiring awake, cortical mapping for brain tumor resection or implantation of intracranial electrodes for extraoperative monitoring for epilepsy
  • For extraoperative patients: Planned electrode coverage including at least parts of frontal and temporal or parietal lobes, preferably both anterior (inferior frontal gyrus) and posterior language areas (superior temporal gyrus) in the language dominant hemisphere
  • For intraoperative patients: Planned craniotomy including parts of both frontal and temporal anterior and posterior language areas in the language dominant hemisphere.
  • Exclusion Criteria:
  • Significant language or speech impairment, including but not limited to aphasia, dysarthria, and apraxia of speech, consistently preventing patient from speaking words
  • Non English-speaking (because this is a study of language networks, and second language could be encoded differently)
  • Impaired cognitive function, as determined by neurological testing, such that the patient cannot follow test instructions or provide written informed consent
  • Tumor infiltrating, or within 1 cm of, multiple of the cortical or subcortical areas studied in this proposal (inferior frontal gyrus, precentral gyrus, superior temporal gyrus)
  • Ferromagnetic implants that are MRI incompatible or other contraindications to MRI
  • Pregnancy

About Northwestern University

Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.

Locations

Chicago, Illinois, United States

Baltimore, Maryland, United States

Iowa City, Iowa, United States

Baltimore, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Marc Slutzky

Principal Investigator

Northwestern University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported